Standard BioTools Return on Investment 2011-2025 | LAB
Current and historical return on investment (ROI) values for Standard BioTools (LAB) over the last 10 years.
| Standard BioTools ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-06-30 | $-0.14B | $0.43B | -31.27% |
| 2025-03-31 | $-0.15B | $0.46B | -30.71% |
| 2024-12-31 | $-0.18B | $0.47B | -34.13% |
| 2024-09-30 | $-0.14B | $0.49B | -32.76% |
| 2024-06-30 | $-0.13B | $0.51B | -35.32% |
| 2024-03-31 | $-0.12B | $0.58B | -38.29% |
| 2023-12-31 | $-0.08B | $0.17B | -32.31% |
| 2023-09-30 | $-0.08B | $0.24B | -28.49% |
| 2023-06-30 | $-0.08B | $0.26B | -29.47% |
| 2023-03-31 | $-0.11B | $0.28B | -34.78% |
| 2022-12-31 | $-0.12B | $0.29B | -43.94% |
| 2022-09-30 | $-0.11B | $0.31B | -45.97% |
| 2022-06-30 | $-0.10B | $0.34B | -50.13% |
| 2022-03-31 | $-0.08B | $0.12B | -50.08% |
| 2021-12-31 | $-0.07B | $0.16B | -40.48% |
| 2021-09-30 | $-0.07B | $0.16B | -41.95% |
| 2021-06-30 | $-0.06B | $0.16B | -31.39% |
| 2021-03-31 | $-0.06B | $0.18B | -28.83% |
| 2020-12-31 | $-0.05B | $0.19B | -26.12% |
| 2020-09-30 | $-0.04B | $0.21B | -21.64% |
| 2020-06-30 | $-0.05B | $0.19B | -25.97% |
| 2020-03-31 | $-0.05B | $0.20B | -25.36% |
| 2019-12-31 | $-0.05B | $0.21B | -23.83% |
| 2019-09-30 | $-0.05B | $0.21B | -23.74% |
| 2019-06-30 | $-0.05B | $0.22B | -23.37% |
| 2019-03-31 | $-0.05B | $0.23B | -22.99% |
| 2018-12-31 | $-0.05B | $0.24B | -23.03% |
| 2018-09-30 | $-0.05B | $0.19B | -22.57% |
| 2018-06-30 | $-0.05B | $0.20B | -23.31% |
| 2018-03-31 | $-0.05B | $0.21B | -24.22% |
| 2017-12-31 | $-0.06B | $0.23B | -25.85% |
| 2017-09-30 | $-0.07B | $0.23B | -29.09% |
| 2017-06-30 | $-0.07B | $0.22B | -29.05% |
| 2017-03-31 | $-0.07B | $0.23B | -28.13% |
| 2016-12-31 | $-0.07B | $0.25B | -26.94% |
| 2016-09-30 | $-0.07B | $0.26B | -24.08% |
| 2016-06-30 | $-0.06B | $0.28B | -19.62% |
| 2016-03-31 | $-0.06B | $0.29B | -17.88% |
| 2015-12-31 | $-0.05B | $0.31B | -15.73% |
| 2015-09-30 | $-0.05B | $0.32B | -14.10% |
| 2015-06-30 | $-0.05B | $0.33B | -15.26% |
| 2015-03-31 | $-0.05B | $0.34B | -14.09% |
| 2014-12-31 | $-0.05B | $0.35B | -14.69% |
| 2014-09-30 | $-0.05B | $0.35B | -17.57% |
| 2014-06-30 | $-0.04B | $0.36B | -21.67% |
| 2014-03-31 | $-0.03B | $0.36B | -34.16% |
| 2013-12-31 | $-0.02B | 0.00% | |
| 2013-09-30 | $-0.02B | 0.00% | |
| 2013-06-30 | $-0.02B | 0.00% | |
| 2013-03-31 | $-0.02B | 0.00% | |
| 2012-12-31 | $-0.02B | 0.00% | |
| 2012-09-30 | $-0.02B | -117.24% | |
| 2012-06-30 | $-0.02B | -56.67% | |
| 2012-03-31 | $-0.02B | -42.78% | |
| 2011-12-31 | $-0.02B | $0.06B | -29.01% |
| 2011-09-30 | $-0.02B | $0.06B | -288.00% |
| 2011-06-30 | $-0.02B | $0.07B | 251.85% |
| 2011-03-31 | $-0.01B | $0.08B | 59.57% |
| 2010-12-31 | $-0.01B | $-0.18B | 33.14% |
| 2010-06-30 | $-0.02B | -193.94% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.458B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $49.025B | 59.82 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $9.874B | 40.87 |
| Hims & Hers Health (HIMS) | United States | $9.049B | 73.61 |
| IRhythm Technologies (IRTC) | United States | $5.681B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.991B | 187.08 |
| Heartflow (HTFL) | United States | $2.850B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.632B | 43.55 |
| 10x Genomics (TXG) | United States | $2.065B | 0.00 |
| Enovis (ENOV) | United States | $1.802B | 9.46 |
| Omnicell (OMCL) | United States | $1.665B | 34.05 |
| Azenta (AZTA) | United States | $1.405B | 61.32 |
| Phreesia (PHR) | United States | $1.363B | 0.00 |
| Schrodinger (SDGR) | United States | $1.347B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.307B | 0.00 |
| Claritev (CTEV) | United States | $0.943B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.877B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.621B | 0.00 |
| Evolent Health (EVH) | United States | $0.592B | 0.00 |
| Talkspace (TALK) | United States | $0.585B | 117.67 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.381B | 0.00 |
| Carlsmed (CARL) | United States | $0.324B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.312B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| CapsoVision (CV) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.192B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.190B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.172B | 0.00 |
| CareCloud (CCLD) | United States | $0.140B | 7.70 |
| EUDA Health Holdings (EUDA) | Singapore | $0.116B | 0.00 |
| Outset Medical (OM) | United States | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |